Methodological problems in genetic association studies of longevity - The apolipoprotein E gene as an example

International Journal of Epidemiology

Volumn 33, Issue 5, 2004, Pages 962-970

  Lewis, Sarah J ^a,b   Brunner, Eric J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Ageing; APOE; Gene; Genetic association; Longevity; Methodology

Indexed keywords

APOLIPOPROTEIN E;

AGING; GENETICS; LIFE EXPECTANCY; METHODOLOGY;

ADULT; AGED; AGING; ALLELE; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; LIFE EXPECTANCY; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION DISTRIBUTION; POPULATION GENETICS; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

AGING; APOLIPOPROTEINS E; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; LONGEVITY; POLYMORPHISM, GENETIC;

EID: 7244254369     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh214     Document Type: Review

References (56)

1. Cournil A, Kirkwood TBL. If you would live long, choose your parents well. Trends Genet 2001;17:233-35.
2. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002;4:45-61.
3. Heijmans BT, Westendorp RGJ, Slagboom PE. Common gene variants, mortality and extreme longevity in humans. Exp Gerontol 2000;35:865-77.
4. De Benedictis G, Tan Q, Jeune B et al. Recent advances in human gene-longevity association studies. Mech Ageing Dev 2001;122: 909-20.
5. Vijg J, van Orsouw N. Searching for genetic determinants of human aging and longevity: opportunities and challenges. Mech Ageing Dev 2002;123:195-205.
6. Schachter F, Cohen D, Kirkwood T. Prospects for the genetics of human longevity. Hum Genet 1993;91:519-26.
7. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease, a meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-55.
8. Rubinsztein DC, Easton DF. Apolipoprotein E genetic variation and Alzheimer's disease. a meta-analysis. Dement Geriatr Cogn Disord 1999;10:199-209.
9. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic-association studies. Nat Genet 2001;29:306-09.
10. Cardon LR, Bell JI. Association study designs for complex diseases. Nat Rev Genet 2001;2:91-99.
11. Colhoun HM, McKeigue, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003;361 1-8.
12. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
13. Census 2001. The Stationery Office, ONS, London, 2001.
14. Dobson J, McLaughlan G. International migration to and from the United Kingdom 1975-1999: consistency, change and implications for the labour market. Popul Trends 2001;106:29-38.
15. Mascie-Taylor CG, Lasker GW. Effect of interregional migration on geographic variability in biological and social trends in Britain. Hum Biol 1995;67:629-40.
16. Office for National Statistics. The Health of Adult Britain 1841-1994. The Stationery Office, ONS. London 1998.
17. Davey Smith G, Marmot MG. Trends in mortality in Britain: 1920-1986. Ann Nutr Metab 1991;35:53-63.
18. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002;88:119-124.
19. Smith JD. Apolipoproteins and aging: emerging mechanisms. Ageing Res Rev 2002;1:345-65.
20. Davignon J, Bouthillier S, Nestruck C, Sing CF. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc 1987;99 100-10.
21. Schächter F, Faure-Delanef L, Guénot F et al. Genetic associations with human longevity at the APOE and ACE loci. Nature Genet 1994;8:29-32.
22. Kervinen K, Savolainen MJ, Salokannel J et al. Apolipoprotein E and B polymorphisms - Longevity factors assessed in nonagenarians. Atheroscerosis 1994:126:89-95.
23. Louhija J, Miettinen K, Kontula K, Tikkanen MJ, Miettinen TA, Tivlis RS. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in Centenarians. Arterioscler Thromb 1994;14:1084-89.
24. Galinsky D, Tysoe C, Brayne CE et al. Atherosclerosis. Analysis of the apo E/ apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997;129:177-83.
25. Hirose N, Homma S, Arai Y et al. Tokyo Centenarian Study. 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo metropolitan area. Nippon Ronen Igakkai Zasshi 1997; 4 267-72.
26. Bader G, Zuliani G, Kostner GM, Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Gerontology 1998;44 293-99.
27. Jian-Gang Z, Yong-Xing M, Chuan-Fu W et al. Apolipoprotein E and longevity among Han Chinese population. Mech Ageing Dev 1998;104:159-67.
28. Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: Apolipoprotein E gene is a 'frailty gene', not a 'longevity gene'. Genet Epidemiol 2000;19:202-10.
29. Rea IM, McDowell I, McMaster D, Smye M, Stout R, Evans A. Apolipoprotein E alleles in nonagenarian subjects in the Belfast elderly longitudinal free-living ageing study (BELFAST). Mech Ageing Dev 2001;122:1367-72.
30. Blanche H, Cabanne L, Sahbatou M, Thomas G. A study of French Centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 2001;324:129-35.
31. Wang X, Wang G, Yang C, Xuan L. Apolipoprotein E gene polymorphism and it's association with human longevity in Uygar nationality in Xinjiang. Chin Med J 2001;114:817-20.
32. Zubenko, GS, Stiffler S, Hughes HB, Fatigati MJ, Zubenko WN. Genome survey for loci that influence successful aging: sample characterization, method validation, and initial results for the Y chromosome. Am J Geriatr Psychiatry 2002;10:619-30.
33. Choi YH, Kim JH, Kim DK et al. Distributions of ACE and APOE Polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol A Biol Sci Med Sci 2003;58:227-31.
34. Panza F, Solfrizzi V, Colacicco AM et al. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and Centenarians. Neuroreport 2003; 14:605-08.
35. Schiele F, De Bacquer D, Vincent-Viry M et al. Apolipoprotein E serum concentration and polymorphism in six European countries: The ApoEurope project. Atherosclerosis 2000;152 475-88.
36. Frikke-Schmidt R, Tybjaerg-Hansen A, Steffensen R, Jensen G, Nordestgaard BG. Apolipoprotein E genotype: epsilon 32 women are protected while epsilon 43 and epsilon 44 men are susceptible to ischemic heart disease. The Copenhagen city heart study. J Am Coll Cardiol 2000;35:1192-99.
37. Thomson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Statist Med 1997; 16: 2741-58.
38. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50 1088-101.
39. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 629-34.
40. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet 1999;63:301-10.
41. United Nations Population Division, Department of Economic and Social Affairs. International Migration 2002. United Nations Publication 2002.
42. Haddy N, De Bacquer D, Chemaly MM et al. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet 2002;10:841-50.
43. Wang J, Whitlock MC. Estimating effective population size and migration rates from genetic samples over space and time. Genetics 2003;163:429-46.
44. Lehtinen S, Luoma P, Lehtimaki T, Nayba S, Hassi J, Nikkari T. Differences in genetic variation of apolipoprotein in Lapps and Finns. Atherosclerosis 1994;109:263.
45. Corbo RM, Scacchi R, Mureddu L, Mulas G, Alfano G. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrylamide gel isoelectric focusing technique. Comparison with frequency data of other European populations. Ann Hum Genet 1995; 59:197-209.
46. Stengård JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet 1998;103:234-41.
47. Sing CF, Stengård JH, Kardia SLR. Genes, environment and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003; 23 1190-96.
48. Ewbank DC. Mortality differences by APOE genotype estimated by APOE genotype estimated from demographic synthesis. Genet Epidemiol 2002;22:146-55.
49. Tilvis RS, STrandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-15.
50. Slooter AJC. Apolipoprotein E and longevity: the Rotterdam study. J Am Geriatr Soc 2001;49:1258-59.
51. Louhija J, Aguero-Torres H, Tilvis R. Survival in the Finnish centenarians in relation to apolipoprotein E polymorphism. J Am Geriatr Soc 2001;49:1007-08.
52. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-69.
53. Stengard JH, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Genotypes with the apolipoprotein episilon 4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum Genet 1996;97:677-84.
54. Corder EH, Lannfelt L, Vittanen M et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996;53:418-22.
55. Lee JH, Tang MX, Schupf N et al. Mortality and apolipoprotein E in Hispanic, African-American and Caucasian Elders. Am J Med Genet 2001;103:121-27.
56. Vogt MT, Cauley JA, Kuller LH. Apolipoprotein E phenotype, arterial disease and mortality among older women: the study of osteoporotic fractures. Genet Epidemiol 1997;14:147-56.